NASDAQ:CRBU Stock Quote
0.8411
+0.00 (0.00%)
Caribou Biosciences Inc is a biotechnology company focused on developing transformative cellular therapies using its proprietary CRISPR genome-editing technology
The company leverages its innovative platform to create engineered immune cells for the treatment of various cancers and other serious diseases. By harnessing the power of CRISPR, Caribou aims to enhance the precision and effectiveness of therapies, ultimately improving patient outcomes and advancing the field of genetic medicine.